3,3',5-triiodothyroacetic acid has been researched along with Atrophy in 3 studies
tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, we have evaluated the dose response effect of thyroid hormone (TH) analogues and tretinoin on glucocorticoid-induced skin atrophy in a haired mouse model." | 3.73 | Action of topical thyroid hormone analogues on glucocorticoid-induced skin atrophy in mice. ( Carlsson, B; Faergemann, J; Hedner, T; Sun, XY; Yazdanparast, P; Zhao, XH, 2006) |
| " In this investigation the effect of topical tri-iodothyroacetic acid (Triac) and other thyroid hormone analogues were tested for their effect in preventing betamethasone-induced skin atrophy in the normal haired mouse." | 3.71 | Dose-response effects of tri-iodothyroacetic acid (Triac) and other thyroid hormone analogues on glucocorticoid-induced skin atrophy in the haired mouse. ( Carlsson, B; Faergemann, J; Hedner, E; Lavin, T; Särnhult, T; Sun, XY; Zhao, XH, 2002) |
| " A total of 39 patients with clinically verified skin atrophy due to long-term use of topical potent glucocorticoids were randomized." | 2.72 | Action of topical thyroid hormone analogue, triiodothyroacetic acid in reversing glucocorticoid-induced skin atrophy in humans. ( Carlsson, B; Faergemann, J; Lavin, T; Oikarinen, A; Risteli, J; Yazdanparast, P, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faergemann, J | 3 |
| Särnhult, T | 1 |
| Hedner, E | 1 |
| Carlsson, B | 3 |
| Lavin, T | 2 |
| Zhao, XH | 2 |
| Sun, XY | 2 |
| Yazdanparast, P | 2 |
| Hedner, T | 1 |
| Oikarinen, A | 1 |
| Risteli, J | 1 |
1 trial available for 3,3',5-triiodothyroacetic acid and Atrophy
| Article | Year |
|---|---|
Action of topical thyroid hormone analogue, triiodothyroacetic acid in reversing glucocorticoid-induced skin atrophy in humans.
Topics: Administration, Topical; Adult; Aged; Atrophy; Biopsy; Dermis; Elastic Tissue; Epidermis; Female; Gl | 2006 |
2 other studies available for 3,3',5-triiodothyroacetic acid and Atrophy
| Article | Year |
|---|---|
Dose-response effects of tri-iodothyroacetic acid (Triac) and other thyroid hormone analogues on glucocorticoid-induced skin atrophy in the haired mouse.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Atrophy; Betamethasone; Glucocorticoids; | 2002 |
Action of topical thyroid hormone analogues on glucocorticoid-induced skin atrophy in mice.
Topics: Acetates; Animals; Atrophy; Betamethasone Valerate; Diiodothyronines; Female; Glucocorticoids; Male; | 2006 |